Literature DB >> 15187432

Comparative study of the inhibition of metallo-beta-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group.

Wanchun Jin1, Yoshichika Arakawa, Hisami Yasuzawa, Tomoko Taki, Ryo Hashiguchi, Kana Mitsutani, Asumi Shoga, Yoshihiro Yamaguchi, Hiromasa Kurosaki, Naohiro Shibata, Michio Ohta, Masafumi Goto.   

Abstract

For the purpose of screening of inhibitors that are effective for wide range of metallo-beta-lactamases, the inhibitory effect of two series of compounds, 2-omega-phenylalkyl-3-mercaptopropionic acid (PhenylCnSH (n=1-4)) and N-[(7-chloro-quinolin-4-ylamino)-alkyl]-3-mercapto-propionamide (QuinolineCnSH (n=2-6)), where n denotes the alkyl chain length, on metallo-beta-lactamases IMP-1 and VIM-2 was examined. These inhibitors contain a thiol group and a hydrophobic group linked by variable-length methylene chain. PhenylCnSH (n=1-4) was found to be a potent inhibitor of both IMP-1 and VIM-2. PhenylC4SH was the potent inhibitor of both IMP-1 (IC(50)=1.2 microM) and VIM-2 (IC(50)=1.1 microM) among this study. When the number of methylene units was varied, QuinolineC4SH showed the maximum inhibitory activity against IMP-1 and VIM-2 (IC(50)=2.5 microM and IC(50)=2.4 microM). The relationship between the inhibitory effect of the alkyl chain length was different for both series of inhibitors, suggesting that IMP-1 has a tighter binding site than VIM-2. QuinolineCnSH did not serve as a fluorescence reagent for metallo-beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187432     DOI: 10.1248/bpb.27.851

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

1.  Syntheses and Biological Evaluations of Highly Functionalized Hydroxamate Containing and N-Methylthio Monobactams as Anti-Tuberculosis and β-Lactamase Inhibitory Agents.

Authors:  Mark W Majewski; Kyle D Watson; Sanghyun Cho; Patricia A Miller; Scott G Franzblau; Marvin J Miller
Journal:  Medchemcomm       Date:  2015-10-05       Impact factor: 3.597

2.  NH-1,2,3-Triazole-based Inhibitors of the VIM-2 Metallo-β-Lactamase: Synthesis and Structure-Activity Studies.

Authors:  Timo Weide; S Adrian Saldanha; Dmitriy Minond; Timothy P Spicer; Joseph R Fotsing; Michael Spaargaren; Jean-Marie Frère; Carine Bebrone; K Barry Sharpless; Peter S Hodder; Valery V Fokin
Journal:  ACS Med Chem Lett       Date:  2010-07-08       Impact factor: 4.345

Review 3.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Structural Insights into TMB-1 and the Role of Residues 119 and 228 in Substrate and Inhibitor Binding.

Authors:  Susann Skagseth; Tony Christopeit; Sundus Akhter; Annette Bayer; Ørjan Samuelsen; Hanna-Kirsti S Leiros
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.

Authors:  L E Horsfall; G Garau; B M R Liénard; O Dideberg; C J Schofield; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

6.  Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?

Authors:  Peter Oelschlaeger; Ni Ai; Kevin T Duprez; William J Welsh; Jeffrey H Toney
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

7.  4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria.

Authors:  Jayakumar K Natarajan; John N Alumasa; Kimberly Yearick; Kekeli A Ekoue-Kovi; Leah B Casabianca; Angel C de Dios; Christian Wolf; Paul D Roepe
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

8.  Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-β-lactamase-1.

Authors:  Francesca Spyrakis; Giuseppe Celenza; Francesca Marcoccia; Matteo Santucci; Simon Cross; Pierangelo Bellio; Laura Cendron; Mariagrazia Perilli; Donatella Tondi
Journal:  ACS Med Chem Lett       Date:  2017-11-26       Impact factor: 4.345

9.  Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.

Authors:  Dmitriy Minond; S Adrian Saldanha; Prem Subramaniam; Michael Spaargaren; Timothy Spicer; Joseph R Fotsing; Timo Weide; Valery V Fokin; K Barry Sharpless; Moreno Galleni; Carine Bebrone; Patricia Lassaux; Peter Hodder
Journal:  Bioorg Med Chem       Date:  2009-06-22       Impact factor: 3.641

10.  Structure of apo- and monometalated forms of NDM-1--a highly potent carbapenem-hydrolyzing metallo-β-lactamase.

Authors:  Youngchang Kim; Christine Tesar; Joseph Mire; Robert Jedrzejczak; Andrew Binkowski; Gyorgy Babnigg; James Sacchettini; Andrzej Joachimiak
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.